BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Saus E, Iraola-Guzmán S, Willis JR, Brunet-Vega A, Gabaldón T. Microbiome and colorectal cancer: Roles in carcinogenesis and clinical potential. Mol Aspects Med 2019;69:93-106. [PMID: 31082399 DOI: 10.1016/j.mam.2019.05.001] [Cited by in Crossref: 67] [Cited by in F6Publishing: 54] [Article Influence: 22.3] [Reference Citation Analysis]
Number Citing Articles
1 Genua F, Raghunathan V, Jenab M, Gallagher WM, Hughes DJ. The Role of Gut Barrier Dysfunction and Microbiome Dysbiosis in Colorectal Cancer Development. Front Oncol 2021;11:626349. [PMID: 33937029 DOI: 10.3389/fonc.2021.626349] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
2 Nguyen HT, Kacimi SEO, Nguyen TL, Suman KH, Lemus-Martin R, Saleem H, Do DN. MiR-21 in the Cancers of the Digestive System and Its Potential Role as a Diagnostic, Predictive, and Therapeutic Biomarker. Biology (Basel) 2021;10:417. [PMID: 34066762 DOI: 10.3390/biology10050417] [Reference Citation Analysis]
3 Hut EF, Radulescu M, Pilut N, Macasoi I, Berceanu D, Coricovac D, Pinzaru I, Cretu O, Dehelean C. Two Antibiotics, Ampicillin and Tetracycline, Exert Different Effects in HT-29 Colorectal Adenocarcinoma Cells in Terms of Cell Viability and Migration Capacity. Curr Oncol 2021;28:2466-80. [PMID: 34287268 DOI: 10.3390/curroncol28040225] [Reference Citation Analysis]
4 Hanus M, Parada-Venegas D, Landskron G, Wielandt AM, Hurtado C, Alvarez K, Hermoso MA, López-Köstner F, De la Fuente M. Immune System, Microbiota, and Microbial Metabolites: The Unresolved Triad in Colorectal Cancer Microenvironment. Front Immunol 2021;12:612826. [PMID: 33841394 DOI: 10.3389/fimmu.2021.612826] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Wang K, Song M. Personalized nutrition for colorectal cancer. Adv Cancer Res 2021;151:109-36. [PMID: 34148612 DOI: 10.1016/bs.acr.2021.02.004] [Reference Citation Analysis]
6 Scavizzi F, Bassi C, Lupini L, Guerriero P, Raspa M, Sabbioni S. A comprehensive approach for microbiota and health monitoring in mouse colonies using metagenomic shotgun sequencing. Anim Microbiome 2021;3:53. [PMID: 34325744 DOI: 10.1186/s42523-021-00113-4] [Reference Citation Analysis]
7 Borgognone A, Serna G, Noguera-Julian M, Alonso L, Parera M, Català-Moll F, Sanchez L, Fasani R, Paredes R, Nuciforo P. Performance of 16S Metagenomic Profiling in Formalin-Fixed Paraffin-Embedded versus Fresh-Frozen Colorectal Cancer Tissues. Cancers (Basel) 2021;13:5421. [PMID: 34771584 DOI: 10.3390/cancers13215421] [Reference Citation Analysis]
8 Kim JR, Han K, Han Y, Kang N, Shin TS, Park HJ, Kim H, Kwon W, Lee S, Kim YK, Park T, Jang JY. Microbiome Markers of Pancreatic Cancer Based on Bacteria-Derived Extracellular Vesicles Acquired from Blood Samples: A Retrospective Propensity Score Matching Analysis. Biology (Basel) 2021;10:219. [PMID: 33805810 DOI: 10.3390/biology10030219] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
9 Chakraborty D, Wang J. Nonalcoholic fatty liver disease and colorectal cancer: Correlation and missing links. Life Sci 2020;262:118507. [PMID: 33017572 DOI: 10.1016/j.lfs.2020.118507] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
10 Perumal K, Ahmad S, Mohd-zahid MH, Wan Hanaffi WN, Z.a. I, Six J, Ferji K, Jaafar J, Boer JC, Plebanski M, Uskoković V, Mohamud R. Nanoparticles and Gut Microbiota in Colorectal Cancer. Front Nanotechnol 2021;3:681760. [DOI: 10.3389/fnano.2021.681760] [Reference Citation Analysis]
11 Choudhry H. The Microbiome and Its Implications in Cancer Immunotherapy. Molecules 2021;26:E206. [PMID: 33401586 DOI: 10.3390/molecules26010206] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
12 Phipps O, Al-Hassi HO, Quraishi MN, Kumar A, Brookes MJ. Influence of Iron on the Gut Microbiota in Colorectal Cancer. Nutrients 2020;12:E2512. [PMID: 32825236 DOI: 10.3390/nu12092512] [Cited by in Crossref: 5] [Cited by in F6Publishing: 3] [Article Influence: 2.5] [Reference Citation Analysis]
13 Ren X, Xu J, Zhang Y, Chen G, Zhang Y, Huang Q, Liu Y. Bacterial Alterations in Post-Cholecystectomy Patients Are Associated With Colorectal Cancer. Front Oncol 2020;10:1418. [PMID: 32903396 DOI: 10.3389/fonc.2020.01418] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
14 Wang X, Li Y, Zhou H, Han N, Pan L, Yu C. Effect of Gambogic Acid on miR-199a-3p Expression and Cell Biological Behavior in Colorectal Cancer Cells. J Oncol 2021;2021:5140621. [PMID: 34484332 DOI: 10.1155/2021/5140621] [Reference Citation Analysis]
15 Crowder SL, Hoogland AI, Welniak TL, LaFranchise EA, Carpenter KM, Li D, Rotroff DM, Mariam A, Pierce CM, Fischer SM, Kinney AY, Dong-Binh Tran T, Rastegari F, Berry DL, Extermann M, Kim RD, Tometich DB, Figueiredo JC, Muzaffar J, Bari S, Turner K, Weinstock GM, Jim HSL. Metagenomics and chemotherapy-induced nausea: A roadmap for future research. Cancer 2021. [PMID: 34643945 DOI: 10.1002/cncr.33892] [Reference Citation Analysis]
16 Gao ZY, Cui Z, Yan YQ, Ning LJ, Wang ZH, Hong J. Microbe-based management for colorectal cancer. Chin Med J (Engl) 2021;134:2922-30. [PMID: 34855639 DOI: 10.1097/CM9.0000000000001887] [Reference Citation Analysis]
17 Bischoff NS, de Kok TM, Sijm DTHM, van Breda SG, Briedé JJ, Castenmiller JJM, Opperhuizen A, Chirino YI, Dirven H, Gott D, Houdeau E, Oomen AG, Poulsen M, Rogler G, van Loveren H. Possible Adverse Effects of Food Additive E171 (Titanium Dioxide) Related to Particle Specific Human Toxicity, Including the Immune System. Int J Mol Sci 2020;22:E207. [PMID: 33379217 DOI: 10.3390/ijms22010207] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
18 Sun H, Huang X, Fu L, Huo B, He T, Jiang X. A powerful adaptive microbiome-based association test for microbial association signals with diverse sparsity levels. J Genet Genomics 2021;48:851-9. [PMID: 34411712 DOI: 10.1016/j.jgg.2021.08.002] [Reference Citation Analysis]
19 Gessani S, Van Duijnhoven FJ, Moreno-Aliaga MJ. Editorial: Diet, Inflammation and Colorectal Cancer. Front Immunol 2019;10:2598. [PMID: 31787978 DOI: 10.3389/fimmu.2019.02598] [Reference Citation Analysis]
20 Huo RX, Wang YJ, Hou SB, Wang W, Zhang CZ, Wan XH. Gut mucosal microbiota profiles linked to colorectal cancer recurrence. World J Gastroenterol 2022; 28(18): 1946-1964 [DOI: 10.3748/wjg.v28.i18.1946] [Reference Citation Analysis]
21 Wu G, Liu J, Liu H, Jin L, Huang X, Mo X, Zhong H, Li Y, Zhang Y, Tang W. An Applicable Inflammation-Joined and Nutrition-Related Prognostic Indicator in Patients With Colorectal Cancer. Front Oncol 2021;11:644670. [PMID: 34221966 DOI: 10.3389/fonc.2021.644670] [Reference Citation Analysis]
22 Chattopadhyay I, Dhar R, Pethusamy K, Seethy A, Srivastava T, Sah R, Sharma J, Karmakar S. Exploring the Role of Gut Microbiome in Colon Cancer. Appl Biochem Biotechnol 2021;193:1780-99. [PMID: 33492552 DOI: 10.1007/s12010-021-03498-9] [Cited by in Crossref: 5] [Cited by in F6Publishing: 6] [Article Influence: 5.0] [Reference Citation Analysis]
23 Huang C, Shi G. Smoking and microbiome in oral, airway, gut and some systemic diseases. J Transl Med. 2019;17:225. [PMID: 31307469 DOI: 10.1186/s12967-019-1971-7] [Cited by in Crossref: 52] [Cited by in F6Publishing: 49] [Article Influence: 17.3] [Reference Citation Analysis]
24 Devi TB, Devadas K, George M, Gandhimathi A, Chouhan D, Retnakumar RJ, Alexander SM, Varghese J, Dharmaseelan S, Chandrika SK, Jissa VT, Das B, Nair GB, Chattopadhyay S. Low Bifidobacterium Abundance in the Lower Gut Microbiota Is Associated With Helicobacter pylori-Related Gastric Ulcer and Gastric Cancer. Front Microbiol 2021;12:631140. [PMID: 33717022 DOI: 10.3389/fmicb.2021.631140] [Cited by in Crossref: 6] [Cited by in F6Publishing: 2] [Article Influence: 6.0] [Reference Citation Analysis]
25 Lu SSM, Mohammed Z, Häggström C, Myte R, Lindquist E, Gylfe Å, Van Guelpen B, Harlid S. Antibiotics Use and Subsequent Risk of Colorectal Cancer: A Swedish Nationwide Population-Based Study. J Natl Cancer Inst 2021:djab125. [PMID: 34467395 DOI: 10.1093/jnci/djab125] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
26 Zouggar A, Haebe JR, Benoit YD. Intestinal Microbiota Influences DNA Methylome and Susceptibility to Colorectal Cancer. Genes (Basel) 2020;11:E808. [PMID: 32708659 DOI: 10.3390/genes11070808] [Cited by in Crossref: 4] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
27 Abu-Ghazaleh N, Chua WJ, Gopalan V. Intestinal microbiota and its association with colon cancer and red/processed meat consumption. J Gastroenterol Hepatol 2021;36:75-88. [PMID: 32198788 DOI: 10.1111/jgh.15042] [Cited by in Crossref: 12] [Cited by in F6Publishing: 14] [Article Influence: 6.0] [Reference Citation Analysis]
28 Ma Y, Qu R, Zhang Y, Jiang C, Zhang Z, Fu W. Progress in the Study of Colorectal Cancer Caused by Altered Gut Microbiota After Cholecystectomy. Front Endocrinol 2022;13:815999. [DOI: 10.3389/fendo.2022.815999] [Reference Citation Analysis]
29 de Souza JB, Brelaz-de-Castro MCA, Cavalcanti IMF. Strategies for the treatment of colorectal cancer caused by gut microbiota. Life Sci 2021;290:120202. [PMID: 34896161 DOI: 10.1016/j.lfs.2021.120202] [Reference Citation Analysis]
30 Cai L, Ying M, Wu H. Microenvironmental Factors Modulating Tumor Lipid Metabolism: Paving the Way to Better Antitumoral Therapy. Front Oncol 2021;11:777273. [PMID: 34888248 DOI: 10.3389/fonc.2021.777273] [Reference Citation Analysis]
31 Parker KD, Maurya AK, Ibrahim H, Rao S, Hove PR, Kumar D, Kant R, Raina B, Agarwal R, Kuhn KA, Raina K, Ryan EP. Dietary Rice Bran-Modified Human Gut Microbial Consortia Confers Protection against Colon Carcinogenesis Following Fecal Transfaunation. Biomedicines 2021;9:144. [PMID: 33546192 DOI: 10.3390/biomedicines9020144] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
32 da Silva Duarte V, Dos Santos Cruz BC, Tarrah A, Sousa Dias R, de Paula Dias Moreira L, Lemos Junior WJF, Fidélis Silva LC, Rocha Santana G, Licursi de Oliveira L, Gouveia Peluzio MDC, Mantovani HC, Corich V, Giacomini A, de Paula SO. Chemoprevention of DMH-Induced Early Colon Carcinogenesis in Male BALB/c Mice by Administration of Lactobacillus Paracasei DTA81. Microorganisms 2020;8:E1994. [PMID: 33327620 DOI: 10.3390/microorganisms8121994] [Cited by in Crossref: 2] [Article Influence: 1.0] [Reference Citation Analysis]
33 dos Santos Cruz BC, da Silva Duarte V, Giacomini A, Corich V, de Paula SO, da Silva Fialho L, Guimarães VM, de Luces Fortes Ferreira CL, Gouveia Peluzio MDC. Synbiotic VSL#3 and yacon-based product modulate the intestinal microbiota and prevent the development of pre-neoplastic lesions in a colorectal carcinogenesis model. Appl Microbiol Biotechnol 2020;104:8837-57. [DOI: 10.1007/s00253-020-10863-x] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 2.0] [Reference Citation Analysis]
34 Zhao H, He M, Zhang M, Sun Q, Zeng S, Chen L, Yang H, Liu M, Ren S, Meng X, Xu H. Colorectal Cancer, Gut Microbiota and Traditional Chinese Medicine: A Systematic Review. Am J Chin Med 2021;49:805-28. [PMID: 33827382 DOI: 10.1142/S0192415X21500385] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 3.0] [Reference Citation Analysis]
35 Nascimento FSD, Suzuki MO, Taba JV, de Mattos VC, Pipek LZ, D'Albuquerque EMC, Iuamoto L, Meyer A, Andraus W, Pinho JRR, de Moura EGH, Setubal JC, Carneiro-D'Albuquerque LA. Analysis of biliary MICRObiota in hepatoBILIOpancreatic diseases compared to healthy people [MICROBILIO]: Study protocol. PLoS One 2020;15:e0242553. [PMID: 33211762 DOI: 10.1371/journal.pone.0242553] [Reference Citation Analysis]
36 Sawicki T, Ruszkowska M, Danielewicz A, Niedźwiedzka E, Arłukowicz T, Przybyłowicz KE. A Review of Colorectal Cancer in Terms of Epidemiology, Risk Factors, Development, Symptoms and Diagnosis. Cancers (Basel) 2021;13:2025. [PMID: 33922197 DOI: 10.3390/cancers13092025] [Cited by in Crossref: 3] [Cited by in F6Publishing: 5] [Article Influence: 3.0] [Reference Citation Analysis]
37 Mann EH, Maughan TS. Fusobacterium nucleatum, rectal cancer and radiotherapy. Ann Oncol 2020;31:1277-8. [PMID: 32629022 DOI: 10.1016/j.annonc.2020.06.019] [Reference Citation Analysis]
38 Li L, Xue C, Zhang T, Wang Y. The interaction between dietary marine components and intestinal flora. Mar Life Sci Technol 2020;2:161-71. [DOI: 10.1007/s42995-020-00035-1] [Cited by in Crossref: 3] [Cited by in F6Publishing: 1] [Article Influence: 1.5] [Reference Citation Analysis]
39 Kattar SA, Jurjus R, Pinon A, Leger DY, Jurjus A, Boukarim C, Diab-Assaf M, Liagre B. Metformin and Probiotics in the Crosstalk between Colitis-Associated Colorectal Cancer and Diabetes in Mice. Cancers (Basel) 2020;12:E1857. [PMID: 32664279 DOI: 10.3390/cancers12071857] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
40 Gigola G, Carriere P, Novoa Díaz MB, Perdigon G, Zwenger AO, Gentili C. Survival effect of probiotics in a rat model of colorectal cancer treated with capecitabine. World J Gastrointest Oncol 2021; 13(10): 1518-1531 [PMID: 34721782 DOI: 10.4251/wjgo.v13.i10.1518] [Reference Citation Analysis]
41 Kalasabail S, Engelman J, Zhang LY, El-Omar E, Yim HCH. A Perspective on the Role of Microbiome for Colorectal Cancer Treatment. Cancers (Basel) 2021;13:4623. [PMID: 34572850 DOI: 10.3390/cancers13184623] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
42 Watson KM, Gaulke CA, Tsikitis VL. Understanding the microbiome: a primer on the role of the microbiome in colorectal neoplasia. Ann Gastroenterol 2020;33:223-36. [PMID: 32382225 DOI: 10.20524/aog.2020.0467] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
43 Maghiari AL, Coricovac D, Pinzaru IA, Macașoi IG, Marcovici I, Simu S, Navolan D, Dehelean C. High Concentrations of Aspartame Induce Pro-Angiogenic Effects in Ovo and Cytotoxic Effects in HT-29 Human Colorectal Carcinoma Cells. Nutrients 2020;12:E3600. [PMID: 33255204 DOI: 10.3390/nu12123600] [Cited by in Crossref: 6] [Cited by in F6Publishing: 6] [Article Influence: 3.0] [Reference Citation Analysis]
44 Tangestani H, Salari-Moghaddam A, Ghalandari H, Emamat H. Adherence to the Dietary Approaches to Stop Hypertension (DASH) dietary pattern reduces the risk of colorectal cancer: A systematic review and meta-analysis. Clin Nutr 2020;39:2975-81. [PMID: 32063407 DOI: 10.1016/j.clnu.2020.02.002] [Cited by in Crossref: 4] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
45 Veziant J, Villéger R, Barnich N, Bonnet M. Gut Microbiota as Potential Biomarker and/or Therapeutic Target to Improve the Management of Cancer: Focus on Colibactin-Producing Escherichia coli in Colorectal Cancer. Cancers (Basel) 2021;13:2215. [PMID: 34063108 DOI: 10.3390/cancers13092215] [Reference Citation Analysis]
46 Zeng X, Jia H, Zhang X, Wang X, Wang Z, Gao Z, Yuan Y, Yue T. Supplementation of kefir ameliorates azoxymethane/dextran sulfate sodium induced colorectal cancer by modulating the gut microbiota. Food Funct 2021;12:11641-55. [PMID: 34724014 DOI: 10.1039/d1fo01729b] [Reference Citation Analysis]
47 Ahmad Kendong SM, Raja Ali RA, Nawawi KNM, Ahmad HF, Mokhtar NM. Gut Dysbiosis and Intestinal Barrier Dysfunction: Potential Explanation for Early-Onset Colorectal Cancer. Front Cell Infect Microbiol 2021;11:744606. [PMID: 34966694 DOI: 10.3389/fcimb.2021.744606] [Reference Citation Analysis]
48 Abolarinwa BA, Ibrahim RB, Huang YH. Conceptual Development of Immunotherapeutic Approaches to Gastrointestinal Cancer. Int J Mol Sci 2019;20:E4624. [PMID: 31540435 DOI: 10.3390/ijms20184624] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 0.7] [Reference Citation Analysis]
49 Mandal S, Bandyopadhyay S, Tyagi K, Roy A. Human microbial dysbiosis as driver of gynecological malignancies. Biochimie 2022:S0300-9084(22)00043-8. [PMID: 35176353 DOI: 10.1016/j.biochi.2022.02.005] [Reference Citation Analysis]
50 Dikeocha IJ, Al-Kabsi AM, Eid EEM, Hussin S, Alshawsh MA. Probiotics supplementation in patients with colorectal cancer: a systematic review of randomized controlled trials. Nutr Rev 2021:nuab006. [PMID: 34027974 DOI: 10.1093/nutrit/nuab006] [Reference Citation Analysis]
51 Nardelli C, Granata I, Nunziato M, Setaro M, Carbone F, Zulli C, Pilone V, Capoluongo ED, De Palma GD, Corcione F, Matarese G, Salvatore F, Sacchetti L. 16S rRNA of Mucosal Colon Microbiome and CCL2 Circulating Levels Are Potential Biomarkers in Colorectal Cancer. Int J Mol Sci 2021;22:10747. [PMID: 34639088 DOI: 10.3390/ijms221910747] [Reference Citation Analysis]
52 Haque S, Raina R, Afroze N, Hussain A, Alsulimani A, Singh V, Mishra BN, Kaul S, Kharwar RN. Microbial dysbiosis and epigenetics modulation in cancer development - A chemopreventive approach. Semin Cancer Biol 2021:S1044-579X(21)00194-2. [PMID: 34216789 DOI: 10.1016/j.semcancer.2021.06.024] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
53 Janney A, Powrie F, Mann EH. Host–microbiota maladaptation in colorectal cancer. Nature 2020;585:509-17. [DOI: 10.1038/s41586-020-2729-3] [Cited by in Crossref: 34] [Cited by in F6Publishing: 34] [Article Influence: 17.0] [Reference Citation Analysis]
54 Kiss B, Mikó E, Sebő É, Toth J, Ujlaki G, Szabó J, Uray K, Bai P, Árkosy P. Oncobiosis and Microbial Metabolite Signaling in Pancreatic Adenocarcinoma. Cancers (Basel) 2020;12:E1068. [PMID: 32344895 DOI: 10.3390/cancers12051068] [Cited by in Crossref: 9] [Cited by in F6Publishing: 9] [Article Influence: 4.5] [Reference Citation Analysis]
55 He Y, Yin J, Lei J, Liu F, Zheng H, Wang S, Wu S, Sheng H, Mcgovern E, Zhou H. Fasting challenges human gut microbiome resilience and reduces Fusobacterium. Medicine in Microecology 2019;1-2:100003. [DOI: 10.1016/j.medmic.2019.100003] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 0.7] [Reference Citation Analysis]
56 Mola S, Pandolfo C, Sica A, Porta C. The Macrophages-Microbiota Interplay in Colorectal Cancer (CRC)-Related Inflammation: Prognostic and Therapeutic Significance. Int J Mol Sci 2020;21:E6866. [PMID: 32962159 DOI: 10.3390/ijms21186866] [Cited by in Crossref: 3] [Cited by in F6Publishing: 4] [Article Influence: 1.5] [Reference Citation Analysis]
57 Gabaldón T. Roles of the human microbiome in cancer. Hepatobiliary Surg Nutr 2021;10:558-60. [PMID: 34430543 DOI: 10.21037/hbsn-21-241] [Reference Citation Analysis]
58 Xu J, Yang M, Wang D, Zhang S, Yan S, Zhu Y, Chen W. Alteration of the abundance of Parvimonas micra in the gut along the adenoma-carcinoma sequence. Oncol Lett 2020;20:106. [PMID: 32831925 DOI: 10.3892/ol.2020.11967] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
59 Vacante M, Ciuni R, Basile F, Biondi A. Gut Microbiota and Colorectal Cancer Development: A Closer Look to the Adenoma-Carcinoma Sequence. Biomedicines. 2020;8. [PMID: 33182693 DOI: 10.3390/biomedicines8110489] [Cited by in Crossref: 5] [Cited by in F6Publishing: 5] [Article Influence: 2.5] [Reference Citation Analysis]
60 Nalluri H, Subramanian S, Staley C. Intestinal organoids: a model to study the role of microbiota in the colonic tumor microenvironment. Future Microbiol 2020;15:1583-94. [PMID: 33215543 DOI: 10.2217/fmb-2019-0345] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 1.5] [Reference Citation Analysis]
61 Sędzikowska A, Szablewski L. Human Gut Microbiota in Health and Selected Cancers. Int J Mol Sci 2021;22:13440. [PMID: 34948234 DOI: 10.3390/ijms222413440] [Reference Citation Analysis]
62 De Santis S, Liso M, Vacca M, Verna G, Cavalcanti E, Coletta S, Calabrese FM, Eri R, Lippolis A, Armentano R, Mastronardi M, De Angelis M, Chieppa M. Dysbiosis Triggers ACF Development in Genetically Predisposed Subjects. Cancers (Basel) 2021;13:283. [PMID: 33466665 DOI: 10.3390/cancers13020283] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
63 Costantini L, Molinari R, Farinon B, Merendino N. Retinoic Acids in the Treatment of Most Lethal Solid Cancers. J Clin Med 2020;9:E360. [PMID: 32012980 DOI: 10.3390/jcm9020360] [Cited by in Crossref: 18] [Cited by in F6Publishing: 15] [Article Influence: 9.0] [Reference Citation Analysis]
64 Merali N, Chouari T, Kayani K, Rayner CJ, Jiménez JI, Krell J, Giovannetti E, Bagwan I, Relph K, Rockall TA, Dhillon T, Pandha H, Annels NE, Frampton AE. A Comprehensive Review of the Current and Future Role of the Microbiome in Pancreatic Ductal Adenocarcinoma. Cancers 2022;14:1020. [DOI: 10.3390/cancers14041020] [Reference Citation Analysis]
65 Nunes SC, Serpa J. Recycling the Interspecific Relations with Epithelial Cells: Bacteria and Cancer Metabolic Symbiosis. Adv Exp Med Biol 2020;1219:77-91. [PMID: 32130694 DOI: 10.1007/978-3-030-34025-4_4] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
66 Khalyfa AA, Punatar S, Aslam R, Yarbrough A. Exploring the Inflammatory Pathogenesis of Colorectal Cancer. Diseases 2021;9:79. [PMID: 34842660 DOI: 10.3390/diseases9040079] [Reference Citation Analysis]
67 El Bairi K, Jabi R, Trapani D, Boutallaka H, Ouled Amar Bencheikh B, Bouziane M, Amrani M, Afqir S, Maleb A. Can the microbiota predict response to systemic cancer therapy, surgical outcomes, and survival? The answer is in the gut. Expert Rev Clin Pharmacol 2020;13:403-21. [PMID: 32308061 DOI: 10.1080/17512433.2020.1758063] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 0.5] [Reference Citation Analysis]
68 Choi S, Chung J, Cho ML, Park D, Choi SS. Analysis of changes in microbiome compositions related to the prognosis of colorectal cancer patients based on tissue-derived 16S rRNA sequences. J Transl Med 2021;19:485. [PMID: 34844611 DOI: 10.1186/s12967-021-03154-0] [Reference Citation Analysis]
69 Sayed IM, Ramadan HK, El-mokhtar MA, Abdel-wahid L. Microbiome and gastrointestinal malignancies. Current Opinion in Physiology 2021;22:100451. [DOI: 10.1016/j.cophys.2021.06.005] [Cited by in Crossref: 1] [Article Influence: 1.0] [Reference Citation Analysis]
70 Dikeocha IJ, Al-kabsi AM, Chiu H, Alshawsh MA. Faecalibacterium prausnitzii Ameliorates Colorectal Tumorigenesis and Suppresses Proliferation of HCT116 Colorectal Cancer Cells. Biomedicines 2022;10:1128. [DOI: 10.3390/biomedicines10051128] [Reference Citation Analysis]
71 Rebersek M. Gut microbiome and its role in colorectal cancer. BMC Cancer 2021;21:1325. [PMID: 34895176 DOI: 10.1186/s12885-021-09054-2] [Reference Citation Analysis]
72 Yuan J, Wei Z, Xu X, Ocansey DKW, Cai X, Mao F. The Effects of Mesenchymal Stem Cell on Colorectal Cancer. Stem Cells Int 2021;2021:9136583. [PMID: 34349805 DOI: 10.1155/2021/9136583] [Reference Citation Analysis]
73 Johns MS, Petrelli NJ. Microbiome and colorectal cancer: A review of the past, present, and future. Surg Oncol 2021;37:101560. [PMID: 33848761 DOI: 10.1016/j.suronc.2021.101560] [Reference Citation Analysis]
74 El-Sayed NNE, Al-Otaibi TM, Alonazi M, Masand VH, Barakat A, Almarhoon ZM, Ben Bacha A. Synthesis and Characterization of Some New Quinoxalin-2(1H)one and 2-Methyl-3H-quinazolin-4-one Derivatives Targeting the Onset and Progression of CRC with SRA, Molecular Docking, and ADMET Analyses. Molecules 2021;26:3121. [PMID: 34071141 DOI: 10.3390/molecules26113121] [Reference Citation Analysis]
75 Saeed M, Shoaib A, Kandimalla R, Javed S, Almatroudi A, Gupta R, Aqil F. Microbe-based therapies for colorectal cancer: Advantages and limitations. Semin Cancer Biol 2021:S1044-579X(21)00148-6. [PMID: 34020027 DOI: 10.1016/j.semcancer.2021.05.018] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]